[Federal Register Volume 85, Number 36 (Monday, February 24, 2020)]
[Notices]
[Pages 10455-10456]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-03559]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Substance Abuse and Mental Health Services Administration
Agency Information Collection Activities: Proposed Collection;
Comment Request
In compliance with Section 3506(c)(2)(A) of the Paperwork Reduction
Act of 1995 concerning opportunity for public comment on proposed
collections of information, the Substance Abuse and Mental Health
Services Administration (SAMHSA) will publish periodic summaries of
proposed projects. To request more information on the proposed projects
or to obtain a copy of the information collection plans, call the
SAMHSA Reports Clearance Officer on (240) 276-1243.
Comments are invited on: (a) Whether the proposed collections of
information are necessary for the proper performance of the functions
of the agency, including whether the information shall have practical
utility; (b) the accuracy of the agency's estimate of the burden of the
proposed collection of information; (c) ways to enhance the quality,
utility, and clarity of the information to be collected; and (d) ways
to minimize the burden of the collection of information on respondents,
including through the use of automated collection techniques or other
forms of information technology.
Proposed Project: Program Evaluation for Prevention Contract (PEPC)--
Strategic Prevention Framework for Prescription Drugs (SPF-Rx)
Evaluation (OMB No. 0930-0377)--Revision
The Substance Abuse and Mental Health Services Administration's
(SAMHSA) Center for Behavioral Health Statistics and Quality (CBHSQ)
aims to complete a cross-site evaluation of SAMHSA's Strategic
Prevention Framework for Prescription Drugs (SPF-Rx). SPF-Rx is
designed to address nonmedical use of prescription drugs as well as
opioid overdoses by raising awareness about the dangers of sharing
medications and by working with pharmaceutical and medical communities
on the risks of overprescribing. The SPF-Rx program aims to promote
collaboration between states/tribes and pharmaceutical and medical
communities to understand the risks of overprescribing to youth ages
12-17 and adults 18 years of age and older. The program also aims to
enhance capacity for, and access to, Prescription Drug Monitoring
Program (PDMP) data for prevention purposes. This request for data
collection includes a revision from previously approved OMB
instruments.
The SPF-Rx program's indicators of success are reductions in opioid
overdoses, reduction in prescription drug misuse and improved use of
PDMP data. Data collected through the tools described in this statement
will be used for the national cross-site evaluation of SAMHSA's SPF-Rx
program. This package covers continued data collection through 2023.
The PEPC team will systematically collect and maintain an Annual
Implementation Instrument (AII) and Grantee and Community Level
Outcomes data modules submitted by SPF-Rx grantees through the online
Data Management System (DMS).
SAMHSA is requesting approval for data collection for the SPF-Rx
cross-site evaluation with the following instruments:
Annual Implementation Instrument (AII)--The AII is a survey
instrument collected yearly to monitor state, tribal entity, and
community-level performance, and to evaluate the effectiveness of the
SPF-Rx program. This tool is completed by grantees and sub-recipient
community project directors, and provides process data related to
funding use and effectiveness, organizational capacity, collaboration
with community partners, data infrastructure, planned intervention
targets, intervention implementation, evaluation, contextual factors,
training and technical assistance (T/TA) needs, and sustainability.
Grantee- and Community-Level Outcomes Modules--These modules
collect data on key SPF-Rx program outcomes, including opioid
prescribing patterns and provider use of PDMP. Grantees will provide
outcomes data at the grantee level for their state, tribal area, or
jurisdiction, as well as at the community level for each of their sub-
recipient communities.
Grantee-Level Interview--This qualitative interview will be
administered at the end of the evaluation to obtain information from
the grantee project directors on their programs, staffing, populations
of focus, infrastructure, capacity, lessons learned, and collaboration.
[[Page 10456]]
Annualized Data Collection Burden by Year
----------------------------------------------------------------------------------------------------------------
Number of Responses per Total number Hours per Total burden
Instrument respondents respondent of responses response hours
----------------------------------------------------------------------------------------------------------------
Annual Implementation 148 1 148 4 592
Instrument....................
Grantee-Level Outcomes Module.. 25 1 25 2.5 62.5
Community-Level Outcomes Module 25 4.92 123 1.25 153.75
Grantee-Level Interview........ 25 1 25 1.5 37.5
--------------------------------------------------------------------------------
FY2021..................... 223 ............... 321 .............. 845.75
----------------------------------------------------------------------------------------------------------------
Annual Implementation 148 1 148 4 592
Instrument....................
Grantee-Level Outcomes Module.. 25 1 25 2.5 62.5
Community-Level Outcomes Module 25 4.92 123 1.25 154.75
--------------------------------------------------------------------------------
FY2022..................... 198 ............... 296 .............. 808.25
----------------------------------------------------------------------------------------------------------------
Annual Implementation 39 1 39 4 156
Instrument....................
Grantee-Level Outcomes Module.. 7 1 7 2.5 17.5
Community-Level Outcomes Module 7 4.57 32 1.25 40
--------------------------------------------------------------------------------
FY2023..................... 53 ............... 78 .............. 213.5
----------------------------------------------------------------------------------------------------------------
Send comments to Carlos Graham, SAMHSA Reports Clearance Officer,
5600 Fishers Lane, Room 15E57-A, Rockville, Maryland 20857, OR email a
copy to [email protected]. Written comments should be
received by April 24, 2020.
Carlos Graham,
Social Science Analyst.
[FR Doc. 2020-03559 Filed 2-21-20; 8:45 am]
BILLING CODE 4162-20-P